129 related articles for article (PubMed ID: 3371396)
1. Effect of different Ca2+ entry blockers on dopamine-induced inhibition of in vitro prolactin secretion.
Di Renzo G; Amoroso S; Maida P; Canzoniero L; Nappi C; Taglialatela M; Annunzia L
Eur J Pharmacol; 1988 Feb; 146(2-3):201-6. PubMed ID: 3371396
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the effects of the calcium entry blockers, verapamil, diltiazem and flunarizine against contractions of the rat isolated aorta and portal vein.
Marriott JF
Br J Pharmacol; 1988 Sep; 95(1):145-54. PubMed ID: 3219471
[TBL] [Abstract][Full Text] [Related]
3. Ca2+ antagonists and inhibitory effects of dopamine on isolated rabbit ear artery.
Scriabine A; Pan M
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S107-12. PubMed ID: 2468849
[TBL] [Abstract][Full Text] [Related]
4. Effect of chronic calcium antagonist treatment on dopamine recognition sites in rat striatum.
Govoni S; Di Giovine S; Moresco RM; Battaini F; Trabucchi M
Neurosci Lett; 1988 Apr; 87(1-2):173-7. PubMed ID: 3380334
[TBL] [Abstract][Full Text] [Related]
5. Effect of different organic and inorganic blockers of calcium entry on the release of endogenous dopamine from tuberoinfundibular neurones.
Annunziato L; Amoroso S; Taglialatela M; De Natale G; Di Renzo GF
Neuropharmacology; 1986 May; 25(5):527-32. PubMed ID: 3736788
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
Messing RO; Carpenter CL; Greenberg DA
J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
[TBL] [Abstract][Full Text] [Related]
7. Effects of Ca2+ entry blockers on kainate-induced changes in extracellular amino acids and Ca2+ in vivo.
Lazarewicz JW; Lehmann A; Hamberger A
J Neurosci Res; 1987; 18(2):341-4. PubMed ID: 3155423
[TBL] [Abstract][Full Text] [Related]
8. Calcium channel antagonists and human immunodeficiency virus coat protein-mediated neuronal injury.
Lipton SA
Ann Neurol; 1991 Jul; 30(1):110-4. PubMed ID: 1656845
[TBL] [Abstract][Full Text] [Related]
9. Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain.
Fadda F; Gessa GL; Mosca E; Stefanini E
J Neural Transm; 1989; 75(3):195-200. PubMed ID: 2926382
[TBL] [Abstract][Full Text] [Related]
10. The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum.
Dobrev D; Milde AS; Andreas K; Ravens U
Br J Pharmacol; 1999 May; 127(2):576-82. PubMed ID: 10385261
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of Ca2+ channel blockers on Ca2+ overload induced by lysophosphatidylcholine in cardiomyocytes.
Chen M; Xiao CY; Hashizume H; Abiko Y
Eur J Pharmacol; 1997 Aug; 333(2-3):261-8. PubMed ID: 9314043
[TBL] [Abstract][Full Text] [Related]
12. Dihydropyridine Ca2+ antagonists: potent inhibitors of secretion from normal and transformed pituitary cells.
Enyeart JJ; Aizawa T; Hinkle PM
Am J Physiol; 1985 May; 248(5 Pt 1):C510-9. PubMed ID: 3922229
[TBL] [Abstract][Full Text] [Related]
13. Ca2+ channel agonists enhance thyrotropin-releasing hormone-induced inositol phosphates and prolactin secretion.
Pachter JA; Law GJ; Dannies PS
Eur J Pharmacol; 1991 Apr; 195(3):373-9. PubMed ID: 1714395
[TBL] [Abstract][Full Text] [Related]
14. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
Johnson M; Mitros K; Stone DM; Zobrist R; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1992 May; 261(2):586-91. PubMed ID: 1374469
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of [3H]dopamine uptake by flunarizine.
Devoto P; Pani L; Kuzmin A; De Montis G
Eur J Pharmacol; 1991 Oct; 203(1):67-9. PubMed ID: 1797556
[TBL] [Abstract][Full Text] [Related]
16. The calcium channel blocker LAS 30538, unlike nifedipine, verapamil, diltiazem or flunarizine, potently inhibits insulin secretion in-vivo in rats and dogs.
Gristwood RW; Furman BL; Llenas J; Jauregui J; Berga P
J Pharm Pharmacol; 1992 Oct; 44(10):851-5. PubMed ID: 1360513
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of analgesia and reversal of tolerance to morphine by calcium channel blockers.
Verma V; Mediratta PK; Sharma KK
Indian J Exp Biol; 2001 Jul; 39(7):636-42. PubMed ID: 12019755
[TBL] [Abstract][Full Text] [Related]
18. Diltiazem enhances and flunarizine inhibits nimodipine's antiseizure effects.
Morón MA; Stevens CW; Yaksh TL
Eur J Pharmacol; 1989 Apr; 163(2-3):299-307. PubMed ID: 2721577
[TBL] [Abstract][Full Text] [Related]
19. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
[TBL] [Abstract][Full Text] [Related]
20. Effects of diltiazem or verapamil on calcium uptake and release from chicken skeletal muscle sarcoplasmic reticulum.
Paydar MJ; Pousti A; Farsam H; Amanlou M; Mehr SE; Dehpour AR
Can J Physiol Pharmacol; 2005 Nov; 83(11):967-75. PubMed ID: 16391705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
